Drug profile · INN
tinzaparin sodium
INNOHEP
tinzaparin sodium (INNOHEP) is a antithrombin-iii activator. Route of administration: injection. Current US regulatory status: approved.
Drug details — tinzaparin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
tinzaparin sodium (INNOHEP) is a antithrombin-iii activator. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Antithrombin-III activator
Primary target: Antithrombin-III
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tinzaparin sodium?
tinzaparin sodium (INNOHEP) is a antithrombin-iii activator. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for tinzaparin sodium?
INNOHEP is a marketed brand name for tinzaparin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tinzaparin sodium?
tinzaparin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.